a drug company has been accused of trying to block trials aimed at promoting a ‘ cheap , safe and effective’ treatment for sight loss on the nhs . the respected medical journal says avastin is just as effective at tackling wet age-related macular degeneration ( amd ) as the current treatment , lucentis . drug company novartis has been accused of trying to block trials aimed at promoting a ‘ cheap , safe and effective’ treatment for sight loss which would save the nhs around £102million a year . wet amd is the most common form of blindness in people over 50 .